A PHASE 1, OPEN-LABEL, CROSS-OVER, FIXED SEQUENCE STUDY TO EVALUATE THE EFFECT OF MULTIPLE DOSES OF DS-1971A ON THE SINGLE DOSE PHARMACOKINETICS OF PROBE SUBSTRATES FOR CYP2B6, CYP2C8, CYP2C9, CYP2C19 AND CYP3A4 ENZYMES IN HEALTHY MALE AND FEMALE SUBJECTS

Clinical trial NCT02473627 · COMPLETED

Trial details

NCT number

NCT02473627

Sponsor

Daiichi Sankyo

Status

COMPLETED

Phase

Phase 1

Study type

INTERVENTIONAL

Start date

2015-05-01

Primary completion

2015-07-01

Enrollment

18

View on ClinicalTrials.gov